Diabetes prescribing growth 'does not match prevalence or outcomes'

The cost and volume of prescription items for diabetes has risen dramatically in the last five years, but geographical variations in these figures do not match prevalence, the DoH national clinical director for diabetes has warned.

The number of diabetes-related prescriptions items issued in the last five years has risen by 55 per cent, and the total cost of these items has risen 88 per cent.

The total number of items prescribed in primary care to treat diabetes was 28.4 million in 2006, up 7.4 per cent on the previous year. The cost of these items increased by 13.6 per cent to £561.4 million in 2006.

National clinical director for diabetes Sue Roberts said there was ‘little evidence’ that  variations in prescribing and spending were ‘matched by corresponding contrasts in prevalence or outcome’.

She hopes the figures, released in ‘Prescribing for Diabetes for England’ this week will provoke debate to ‘establish what is happening in terms of prescribing at the frontline’.


nick.bostock@haymarket.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs have demanded urgent action to prevent avoidable harm to patients from the NHS...

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

GP practices will be unable to cope with a second wave of COVID-19 unless urgent...

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Dr Vasu Siva explains how her practice is aiming to cut its carbon emissions by targeting...

RCGP chair warns of 'significant problem' over flu vaccine supplies

RCGP chair warns of 'significant problem' over flu vaccine supplies

The NHS faces a 'significant problem' with flu vaccine supplies as it aims to cover...

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...

Government must show evidence behind PPE strategy, warns BMA

Government must show evidence behind PPE strategy, warns BMA

Chronic shortages of personal protective equipment (PPE) across the NHS during the...